Non-pegylated liposomal doxorubicin in metastatic breast cancer (MBC) – Results from an Austrian post marketing surveillance programme

Veröffentlicht vonadmin

Steger, GG, Mlineritsch, B, Bartsch, R, Pluschnig, U, Petru, E, Peintinger, F, Sevelda, P, Greil, R